APA (7th ed.) Citation

Moorman, A. V., Enshaei, A., Murdy, D., Joy, M., Boer, J. M., den Boer, M. L., . . . Lund University, F. o. M. (2024). Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia, 38(9), 2023. https://doi.org/10.1038/s41375-024-02329-0

Chicago Style (17th ed.) Citation

Moorman, Anthony V., et al. "Integration of Genetics and MRD to Define Low Risk Patients with B-cell Precursor Acute Lymphoblastic Leukaemia with Intermediate MRD Levels at the End of Induction." Leukemia 38, no. 9 (2024): 2023. https://doi.org/10.1038/s41375-024-02329-0.

MLA (9th ed.) Citation

Moorman, Anthony V., et al. "Integration of Genetics and MRD to Define Low Risk Patients with B-cell Precursor Acute Lymphoblastic Leukaemia with Intermediate MRD Levels at the End of Induction." Leukemia, vol. 38, no. 9, 2024, p. 2023, https://doi.org/10.1038/s41375-024-02329-0.